The	The	DT	B-NP	O		0	3
differential	differential	JJ	I-NP	O		4	16
diagnosis	diagnosis	NN	I-NP	O		17	26
of	of	IN	B-PP	O		27	29
early	early	JJ	B-NP	O		30	35
gastric	gastric	JJ	I-NP	O		36	43
mucosa	mucosa	NN	I-NP	O		44	50
-	-	HYPH	B-VP	O		50	51
associated	associate	VBN	B-NP	O		51	61
lymphoma	lymphoma	NN	I-NP	O		62	70
:	:	:	O	O		70	71
polymerase	polymerase	NN	B-NP	O		72	82
chain	chain	NN	I-NP	O		83	88
reaction	reaction	NN	I-NP	O		89	97
and	and	CC	O	O		98	101
paraffin	paraffin	NN	B-NP	O		102	110
section	section	NN	I-NP	O		111	118
immunophenotyping	immunophenotyping	NN	I-NP	O		119	136
.	.	.	O	O		136	137

The	The	DT	B-NP	O		138	141
distinction	distinction	NN	I-NP	O		142	153
between	between	IN	B-PP	O		154	161
benign	benign	JJ	B-NP	O		162	168
florid	florid	NN	I-NP	O		169	175
lymphoid	lymphoid	JJ	I-NP	O		176	184
hyperplasia	hyperplasia	NN	I-NP	O		185	196
and	and	CC	O	O		197	200
low-grade	low-grade	JJ	B-NP	O		201	210
gastric	gastric	JJ	I-NP	O		211	218
mucosal	mucosal	NN	I-NP	O		219	226
-	-	HYPH	O	O		226	227
associated	associate	VBN	B-VP	O		227	237
lymphoid	lymphoid	JJ	B-NP	O		238	246
tissue	tissue	NN	I-NP	O		247	253
(	(	(	O	O		254	255
MALT	MALT	NN	B-NP	O		255	259
)	)	)	O	O		259	260
lymphoma	lymphoma	NN	B-NP	O		261	269
may	may	MD	B-VP	O		270	273
be	be	VB	I-VP	O		274	276
a	a	DT	B-NP	O		277	278
challenge	challenge	NN	I-NP	O		279	288
.	.	.	O	O		288	289

The	The	DT	B-NP	O		290	293
presence	presence	NN	I-NP	O		294	302
of	of	IN	B-PP	O		303	305
monoclonal	monoclonal	JJ	B-NP	B-cell_type		306	316
B	B	NN	I-NP	I-cell_type		317	318
cells	cell	NNS	I-NP	I-cell_type		319	324
in	in	IN	B-PP	O		325	327
Helicobacter pylori	Helicobacter_pylori	NNP	B-NP	O		328	347
-	-	HYPH	B-NP	O		347	348
chronic	chronic	JJ	I-NP	O		348	355
active	active	JJ	I-NP	O		356	362
gastritis	gastritis	NN	I-NP	O		363	372
has	have	VBZ	B-VP	O		373	376
suggested	suggest	VBN	I-VP	O		377	386
that	that	IN	B-SBAR	O		387	391
polymerase	polymerase	NN	B-NP	O		392	402
chain	chain	NN	I-NP	O		403	408
reaction	reaction	NN	I-NP	O		409	417
(	(	(	O	O		418	419
PCR	PCR	NN	B-NP	O		419	422
)	)	)	O	O		422	423
data	datum	NNS	B-NP	O		424	428
should	should	MD	B-VP	O		429	435
be	be	VB	I-VP	O		436	438
viewed	view	VBN	I-VP	O		439	445
with	with	IN	B-PP	O		446	450
caution	caution	NN	B-NP	O		451	458
.	.	.	O	O		458	459

We	We	PRP	B-NP	O		460	462
investigated	investigate	VBD	B-VP	O		463	475
the	the	DT	B-NP	O		476	479
reliability	reliability	NN	I-NP	O		480	491
of	of	IN	B-PP	O		492	494
PCR	PCR	NN	B-NP	O		495	498
versus	versus	CC	I-NP	O		499	505
immunophenotyping	immunophenotyping	NN	I-NP	O		506	523
in	in	IN	B-PP	O		524	526
diagnosing	diagnose	VBG	B-VP	O		527	537
early	early	JJ	B-NP	O		538	543
gastric	gastric	JJ	I-NP	O		544	551
MALT	MALT	NN	I-NP	O		552	556
lymphoma	lymphoma	NN	I-NP	O		557	565
.	.	.	O	O		565	566

We	We	PRP	B-NP	O		567	569
studied	study	VBD	B-VP	O		570	577
1511	1511	CD	B-NP	O		578	582
biopsies	biopsy	NNS	I-NP	O		583	591
from	from	IN	B-PP	O		592	596
eight	eight	CD	B-NP	O		597	602
patients	patient	NNS	I-NP	O		603	611
with	with	IN	B-PP	O		612	616
high	high	JJ	B-NP	O		617	621
-	-	HYPH	I-NP	O		621	622
grade	grade	NN	I-NP	O		622	627
primary	primary	JJ	I-NP	O		628	635
gastric	gastric	JJ	I-NP	O		636	643
lymphoma	lymphoma	NN	I-NP	O		644	652
,	,	,	O	O		652	653
25	25	CD	B-NP	O		654	656
with	with	IN	B-PP	O		657	661
low-grade	low-grade	JJ	B-NP	O		662	671
MALT	MALT	NN	I-NP	O		672	676
lymphoma	lymphoma	NN	I-NP	O		677	685
,	,	,	O	O		685	686
32	32	CD	B-NP	O		687	689
with	with	IN	B-PP	O		690	694
atypical	atypical	JJ	B-NP	B-cell_type		695	703
lymphoid	lymphoid	JJ	I-NP	I-cell_type		704	712
infiltrates	infiltrate	NNS	I-NP	I-cell_type		713	724
,	,	,	O	O		724	725
and	and	CC	O	O		726	729
39	39	CD	B-NP	O		730	732
with	with	IN	B-PP	O		733	737
Helicobacter pylori	Helicobacter_pylori	NNP	B-NP	O		738	757
-	-	HYPH	I-NP	O		757	758
chronic	chronic	JJ	I-NP	O		758	765
active	active	JJ	I-NP	O		766	772
gastritis	gastritis	NN	I-NP	O		773	782
.	.	.	O	O		782	783

Paraffin	Paraffin	NN	B-NP	O		784	792
sections	section	NNS	I-NP	O		793	801
from	from	IN	B-PP	O		802	806
all	all	DT	B-NP	O		807	810
cases	case	NNS	I-NP	O		811	816
were	be	VBD	B-VP	O		817	821
stained	stain	VBN	I-VP	O		822	829
with	with	IN	B-PP	O		830	834
antibodies	antibody	NNS	B-NP	B-protein		835	845
to	to	TO	B-PP	O		846	848
CD20	CD20	NN	B-NP	B-protein		849	853
,	,	,	O	O		853	854
CD3	CD3	NN	B-NP	B-protein		855	858
,	,	,	O	O		858	859
AE1	AE1	NN	B-NP	B-protein		860	863
/	/	SYM	B-NP	O		863	864
AE3	AE3	NN	I-NP	B-protein		864	867
,	,	,	I-NP	O		867	868
kappa	kappa	NN	I-NP	O		869	874
and	and	CC	I-NP	O		875	878
lambda	lambda	NN	I-NP	O		879	885
.	.	.	O	O		885	886

PCR	PCR	NN	B-NP	O		887	890
was	be	VBD	B-VP	O		891	894
performed	perform	VBN	I-VP	O		895	904
on	on	IN	B-PP	O		905	907
paraffin	paraffin	NN	B-NP	O		908	916
sections	section	NNS	I-NP	O		917	925
using	use	VBG	B-VP	O		926	931
the	the	DT	B-NP	O		932	935
primer	primer	NN	I-NP	O		936	942
set	set	NN	I-NP	O		943	946
VH	VH	NN	I-NP	O		947	949
-	-	HYPH	B-NP	O		949	950
FR3	FR3	NN	I-NP	B-protein		950	953
/	/	SYM	B-NP	O		953	954
J(H)	J(H)	NN	I-NP	O		954	958
.	.	.	O	O		958	959

Using	Use	VBG	B-VP	O		960	965
histopathology	histopathology	NN	B-NP	O		966	980
as	as	IN	B-PP	O		981	983
the	the	DT	B-NP	O		984	987
gold	gold	JJ	I-NP	O		988	992
standard	standard	NN	I-NP	O		993	1001
in	in	IN	B-PP	O		1002	1004
diagnosis	diagnosis	NN	B-NP	O		1005	1014
,	,	,	O	O		1014	1015
we	we	PRP	B-NP	O		1016	1018
confirmed	confirm	VBD	B-VP	O		1019	1028
monoclonality	monoclonality	NN	B-NP	O		1029	1042
in	in	IN	B-PP	O		1043	1045
22	22	CD	B-NP	O		1046	1048
of	of	IN	B-PP	O		1049	1051
25	25	CD	B-NP	O		1052	1054
MALT	MALT	NN	I-NP	O		1055	1059
lymphomas	lymphoma	NNS	I-NP	O		1060	1069
(	(	(	O	O		1070	1071
88%	88%	NN	B-NP	O		1071	1074
)	)	)	O	O		1074	1075
;	;	:	O	O		1075	1076
a	a	DT	B-NP	O		1077	1078
clonal	clonal	JJ	I-NP	O		1079	1085
band	band	NN	I-NP	O		1086	1090
was	be	VBD	B-VP	O		1091	1094
found	find	VBN	I-VP	O		1095	1100
in	in	IN	B-PP	O		1101	1103
38%	38%	CD	B-NP	O		1104	1107
(	(	(	O	O		1108	1109
15	15	CD	B-NP	O		1109	1111
of	of	IN	B-PP	O		1112	1114
39	39	CD	B-NP	O		1115	1117
)	)	)	O	O		1117	1118
of	of	IN	B-PP	O		1119	1121
patients	patient	NNS	B-NP	O		1122	1130
with	with	IN	B-PP	O		1131	1135
chronic	chronic	JJ	B-NP	O		1136	1143
active	active	JJ	I-NP	O		1144	1150
gastritis	gastritis	NN	I-NP	O		1151	1160
.	.	.	O	O		1160	1161

An	An	DT	B-NP	O		1162	1164
immunophenotype	immunophenotype	NN	I-NP	O		1165	1180
pattern	pattern	NN	I-NP	O		1181	1188
with	with	IN	B-PP	O		1189	1193
predominance	predominance	NN	B-NP	O		1194	1206
of	of	IN	B-PP	O		1207	1209
CD20	CD20	NN	B-NP	B-protein		1210	1214
-	-	HYPH	B-NP	O		1214	1215
positive	positive	JJ	I-NP	B-cell_type		1215	1223
cells	cell	NNS	I-NP	I-cell_type		1224	1229
in	in	IN	B-PP	O		1230	1232
lymphocytic	lymphocytic	JJ	B-NP	B-cell_type		1233	1244
infiltrates	infiltrate	NNS	I-NP	I-cell_type		1245	1256
was	be	VBD	B-VP	O		1257	1260
associated	associate	VBN	I-VP	O		1261	1271
with	with	IN	B-PP	O		1272	1276
monoclonality	monoclonality	NN	B-NP	O		1277	1290
in	in	IN	B-PP	O		1291	1293
92%	92%	CD	B-NP	O		1294	1297
of	of	IN	B-PP	O		1298	1300
cases	case	NNS	B-NP	O		1301	1306
.	.	.	O	O		1306	1307

The	The	DT	B-NP	O		1308	1311
presence	presence	NN	I-NP	O		1312	1320
of	of	IN	B-PP	O		1321	1323
an	an	DT	B-NP	O		1324	1326
enlarged	enlarged	JJ	I-NP	O		1327	1335
irregular	irregular	JJ	I-NP	O		1336	1345
mantle	mantle	NN	I-NP	O		1346	1352
zone	zone	NN	I-NP	O		1353	1357
was	be	VBD	B-VP	O		1358	1361
found	find	VBN	I-VP	O		1362	1367
in	in	IN	B-PP	O		1368	1370
both	both	CC	B-NP	O		1371	1375
monoclonal	monoclonal	JJ	I-NP	O		1376	1386
and	and	CC	I-NP	O		1387	1390
polyclonal	polyclonal	JJ	I-NP	O		1391	1401
areas	area	NNS	I-NP	O		1402	1407
.	.	.	O	O		1407	1408

An	An	DT	B-NP	O		1409	1411
equal	equal	JJ	I-NP	O		1412	1417
prevalence	prevalence	NN	I-NP	O		1418	1428
of	of	IN	B-PP	O		1429	1431
B	B	NN	B-NP	B-cell_type		1432	1433
and	and	CC	O	I-cell_type		1434	1437
T	T	NN	B-NP	I-cell_type		1438	1439
cells	cell	NNS	B-NP	I-cell_type		1440	1445
in	in	IN	B-PP	O		1446	1448
lymphocytic	lymphocytic	JJ	B-NP	B-cell_type		1449	1460
infiltrates	infiltrate	NNS	I-NP	I-cell_type		1461	1472
was	be	VBD	B-VP	O		1473	1476
associated	associate	VBN	I-VP	O		1477	1487
with	with	IN	B-PP	O		1488	1492
a	a	DT	B-NP	O		1493	1494
polyclonal	polyclonal	JJ	I-NP	O		1495	1505
pattern	pattern	NN	I-NP	O		1506	1513
in	in	IN	B-PP	O		1514	1516
24	24	CD	B-NP	O		1517	1519
of	of	IN	B-PP	O		1520	1522
31	31	CD	B-NP	O		1523	1525
cases	case	NNS	I-NP	O		1526	1531
(	(	(	O	O		1532	1533
77%	77%	CD	B-NP	O		1533	1536
)	)	)	O	O		1536	1537
.	.	.	O	O		1537	1538

Immunostaining	Immunostaining	NN	B-NP	O		1539	1553
of	of	IN	B-PP	O		1554	1556
sIg	sIg	NN	B-NP	B-protein		1557	1560
(	(	(	O	O		1561	1562
kappa	kappa	NN	B-NP	O		1562	1567
and	and	CC	O	O		1568	1571
lambda	lambda	NN	B-NP	O		1572	1578
)	)	)	O	O		1578	1579
was	be	VBD	B-VP	O		1580	1583
difficult	difficult	JJ	B-ADJP	O		1584	1593
in	in	IN	B-PP	O		1594	1596
paraffin	paraffin	NN	B-NP	O		1597	1605
sections	section	NNS	I-NP	O		1606	1614
and	and	CC	O	O		1615	1618
convincing	convince	VBG	B-VP	O		1619	1629
proof	proof	NN	B-NP	O		1630	1635
of	of	IN	B-PP	O		1636	1638
monoclonality	monoclonality	NN	B-NP	O		1639	1652
was	be	VBD	B-VP	O		1653	1656
not	not	RB	I-VP	O		1657	1660
obtained	obtain	VBN	I-VP	O		1661	1669
.	.	.	O	O		1669	1670

Lymphoepithelial	Lymphoepithelial	JJ	B-NP	O		1671	1687
lesions	lesion	NNS	I-NP	O		1688	1695
were	be	VBD	B-VP	O		1696	1700
infrequent	infrequent	JJ	B-ADJP	O		1701	1711
in	in	IN	B-PP	O		1712	1714
gastric	gastric	JJ	B-NP	O		1715	1722
biopsies	biopsy	NNS	I-NP	O		1723	1731
and	and	CC	O	O		1732	1735
their	their	PRP$	B-NP	O		1736	1741
presence	presence	NN	I-NP	O		1742	1750
was	be	VBD	B-VP	O		1751	1754
highlighted	highlight	VBN	I-VP	O		1755	1766
with	with	IN	B-PP	O		1767	1771
keratin	keratin	NN	B-NP	O		1772	1779
stains	stain	NNS	I-NP	O		1780	1786
.	.	.	O	O		1786	1787

Because	Because	IN	B-SBAR	O		1788	1795
monoclonal	monoclonal	JJ	B-NP	B-cell_type		1796	1806
B	B	NN	I-NP	I-cell_type		1807	1808
cells	cell	NNS	I-NP	I-cell_type		1809	1814
are	be	VBP	B-VP	O		1815	1818
observed	observe	VBN	I-VP	O		1819	1827
in	in	IN	B-PP	O		1828	1830
Helicobacter pylori	Helicobacter_pylori	NNP	B-NP	O		1831	1850
-	-	HYPH	B-NP	O		1850	1851
associated	associate	VBN	I-NP	O		1851	1861
gastritis	gastritis	NN	I-NP	O		1862	1871
,	,	,	O	O		1871	1872
the	the	DT	B-NP	O		1873	1876
correct	correct	JJ	I-NP	O		1877	1884
interpretation	interpretation	NN	I-NP	O		1885	1899
of	of	IN	B-PP	O		1900	1902
clonality	clonality	NN	B-NP	O		1903	1912
by	by	IN	B-PP	O		1913	1915
PCR	PCR	NN	B-NP	O		1916	1919
remains	remain	VBZ	B-VP	O		1920	1927
unclear	unclear	JJ	B-ADJP	O		1928	1935
.	.	.	O	O		1935	1936

Paraffin	Paraffin	NN	B-NP	O		1937	1945
section	section	NN	I-NP	O		1946	1953
IHC	IHC	NN	I-NP	O		1954	1957
using	use	VBG	B-VP	O		1958	1963
CD20	CD20	NN	B-NP	B-protein		1964	1968
and	and	CC	I-NP	O		1969	1972
CD3	CD3	NN	I-NP	B-protein		1973	1976
is	be	VBZ	B-VP	O		1977	1979
especially	especially	RB	B-ADJP	O		1980	1990
useful	useful	JJ	I-ADJP	O		1991	1997
to	to	TO	B-VP	O		1998	2000
confirm	confirm	VB	I-VP	O		2001	2008
the	the	DT	B-NP	O		2009	2012
diagnosis	diagnosis	NN	I-NP	O		2013	2022
of	of	IN	B-PP	O		2023	2025
gastric	gastric	JJ	B-NP	O		2026	2033
MALT	MALT	NN	I-NP	O		2034	2038
lymphoma	lymphoma	NN	I-NP	O		2039	2047
.	.	.	O	O		2047	2048

